Irina Koffler

facebook_page
twitter_page

Last quote by Irina Koffler

We view MYL as oversold due to recent uncertainty about the EpiPen franchise and management concerns, and we expect shares to recover once the company provides more visibility and guidance. Additionally, there are a number of potential catalysts that could drive share momentum over the next six months.feedback
Oct 26 2016
Irina Koffler has been quoted 4 times. The two most recent articles where Irina Koffler has been quoted are Endo International CEO steps down; Campanelli named successor and Valeant shares jump 6 percent after analyst says 'short thesis has been debunked'. Most recently, Irina Koffler was quoted as having said, “We are not surprised by this transition as De Silva's skill-set may not be helpful to the new direction of this company.”.
Automatically powered byStoryzy

Quotes by Irina Koffler

<
facebook_page
twitter_page
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided
 
Feedback×

Quote :

Mistake :

Comments :